Clinical Chemistry

5.75 CME Credits

4 February 2020
Dubai World Trade Centre

08:45

Opening remarks

Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Session 1

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

09:00

Introduction: Inherited metabolic disorders in the Middle East

Dr Riad Abdel Latif Bayoumi, Chairman - Basic Medical Sciences Department, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

09:30

Aminoacidopathies interpretation in body fluids: A laboratory approach

Dr Mohamed Elsammak, Consultant Chemical Pathologist, Head of the Metabolic Unit, King Fahad Specialist Hospital, Dammam, KSA

10:00

Metabolic emergencies: The critical relationship between the medical team and the laboratory

Dr Hamda Abulhoul, Al Jalila Children's Specialty Hospital, UAE

10:30 

Coffee break

Session 2

Moderator: Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

11:00

Modern approaches to quality control

Faisal Ibrahim, QA Director, National Reference Laboratory, Abu Dhabi, UAE

11:30

Trust but verify: Autoverification in clinical labs - a quality tool or a medical liability?

Dr Rana Nabulsi, Consultant & Head of Quality, Pathology and Genetics Department, Dubai Health Authority, Dubai, UAE

Dr Laila Abdel Wareth, National Reference Laboratory, Cleveland Clinic Abu Dhabi, UAE

12:00

Engaging the clinician through laboratory interpretive services

Dr James H. Nichols, Professor of Pathology, Microbiology and Immunology; Medical Director, Clinical Chemistry and Point-of-Care Testing; Vanderbilt University School of Medicine, Nashville, Tennessee, USA

12:30 

Lunch break and visit exhibition

Session 3

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

14:00

Contribution of the toxicology laboratory to the diagnosis of drug addiction: Procedures and problems

Prof Abderrazek Hedhili, Professor, Toxicology, Faculty of Pharmacy, Monastir; Faculty of Medicine of Tunis and Health Institutes, Tunis, Tunisia

14:30

Implementation of high sensitivity troponin testing

Dr Brad Karon, Pathologist, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

15:00

Update of new laboratory markers to detect diabetic nephropathy

Dr Waleed Tamimi, Head of Clinical Chemistry Lab and POCT, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, KSA

15:30 

Coffee break

Session 4

Moderator: Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

16:00

Laboratory strategies for mitigating re-analytical errors

Dr Marcia Zucker, Consultant, Point of Care Diagnostics; President, ZIVD, Plaistow, New Hampshire, USA 

16:30

Candidate biomarkers of NAFLD; Promising approach to a silent epidemic

Dr Shereen Atef, National Reference Laboratory, UAE

17:00

End of conference